Group One Trading
IRD

Group One Trading’s Opus Genetics IRD Stock Holding History

Group One Trading’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48.2K Buy
+10,594
New +$36.6K ﹤0.01% 5285
2024
Q3 		– Sell
-76
Closed -$116 – 7505
2024
Q2 		$116 Buy
+76
New +$131 ﹤0.01% 6548
2024
Q1 		– Sell
-708
Closed -$1.79K – 8119
2023
Q4 		$2.13K Sell
708
-1,589
-69% -$4.7K ﹤0.01% 6804
2023
Q3 		$7.7K Buy
+2,297
New +$9.22K ﹤0.01% 6492
2023
Q2 		– Sell
-1,451
Closed -$6.89K – 8305
2023
Q1 		$5.44K Sell
1,451
-3,411
-70% -$12.2K ﹤0.01% 6244
2022
Q4 		$17.2K Buy
+4,862
New +$12.8K ﹤0.01% 5691
2022
Q1 		– Sell
-790
Closed -$2.7K – 8853
2021
Q4 		$3K Sell
790
-30,843
-98% -$124K ﹤0.01% 7822
2021
Q3 		$163K Buy
31,633
+11,656
+58% +$53.7K ﹤0.01% 5382
2021
Q2 		$105K Buy
+19,977
New +$99.2K ﹤0.01% 5903
2018
Q2 		– Sell
-81
Closed -$7.12K – 5550
2018
Q1 		$6K Buy
81
+80
+8,000% +$7.26K ﹤0.01% 4481
2017
Q4 		$0 Hold
1
– – ﹤0.01% 5303
2017
Q3 		$0 Buy
+1
New +$108 ﹤0.01% 5224

Other funds holding IRD

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Group One Trading's IRD Position: Q1 2026 in Review

Group One Trading opened a new position in Opus Genetics (IRD) in Q1 2026: 10,594 shares worth $48.2K. The stake represents ﹤0.01% of the portfolio and ranks #5285 among its holdings. This is a return to the name: Group One Trading previously reported a position in IRD as recently as Q2 2024.

Group One Trading first reported a position in IRD in Q3 2017 and has held it in 12 quarters since. The position peaked at $163K in Q3 2021. 79 funds tracked by Wall St. Rank hold IRD as of Q1 2026.

  • Group One Trading held 10,594 shares of Opus Genetics worth $48.2K as of Q1 2026.
  • Opus Genetics was a new Group One Trading position in Q1 2026.
  • Opus Genetics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #5285 holding.
  • Group One Trading first reported a position in Opus Genetics in Q3 2017 and has held it in 12 quarters since.
  • Group One Trading's Opus Genetics position peaked at $163K in Q3 2021.
  • 79 funds tracked by Wall St. Rank held Opus Genetics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.